• OPEN AN ACCOUNT
Indian Indices
Nifty
24,924.70 916.70
(3.82%)
Sensex
82,429.90 2,975.43
( 3.74%)
Bank Nifty
55,382.85 1,787.60
( 3.34%)
Nifty IT
38,282.55 2,402.45
( 6.70%)
Global Indices
Nasdaq
41,266.30 -123.15
(-0.30%)
Dow Jones
5,680.75 -4.19
(-0.07%)
Hang Seng
37,650.80 147.47
(0.39%)
Nikkei 225
8,604.98 50.18
(0.59%)
Forex
USD-INR
85.39 0.69
(0.81%)
EUR-INR
96.28 0.21
(0.22%)
GBP-INR
113.48 0.52
(0.46%)
JPY-INR
0.59 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Sigachi Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543389
INE0D0K01022
13.4454797
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SIGACHI
26.23
1373.14
EPS(TTM)
Face Value()
Div & Yield %
1.57
1
0.24
 

sigachi industries ltd
Sigachi MENA FZCO signs MoU with Czech Republic-based Respilon
Apr 28,2025

 Sigachi MENA FZCO, a wholly owned subsidiary of Sigachi Industries, has signed a Memorandum of Understanding (MoU) with Respilon, an innovation-driven nanofiber R&D company headquartered in the Czech Republic. This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.

Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon's proprietary NUENEX® nanofiber technology. The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.